19744185Rosner M, Dolznig H, Fuchs C, Siegel N, Valli A, Hengstschläger MEuropean journal of clinical investigationCyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinases; Immunosuppressive Agents; Sirolimus; Tuberous Sclerosis; Tumor Suppressor ProteinsHumans; Intracellular Signaling Peptides and Proteins; Phosphorylation; Protein Serine-Threonine Kinases; TOR Serine-Threonine Kinases; Tuberous Sclerosis Complex 2 ProteinCDKs as therapeutic targets for the human genetic disease tuberous sclerosis? Eur J Clin Invest. 2009 Dec; 39(12):1033-5.Eur J Clin Invest2009-09-09T00:00:002009CDKs as therapeutic targets for the human genetic disease tuberous sclerosis?prns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkAnchorTextlink anchor textvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titleURLLinkvivo:webpagewebpagerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD007166Chemicals & Drugs2179770.66626Immunosuppressive AgentsD010766Phenomena34811010.802856PhosphorylationD006801Living Beings2262862810.130052HumansBen May Department of Cancer ResearchD020123Chemicals & Drugs881690.887297SirolimusD058570Chemicals & Drugs991820.885143TOR Serine-Threonine KinasesD014402Disorders14280.98244Tuberous SclerosisD018844Chemicals & Drugs29430.981808Cyclin-Dependent KinasesD025521Chemicals & Drugs1482790.844953Tumor Suppressor ProteinsD047908Chemicals & Drugs1833780.829617Intracellular Signaling Peptides and ProteinsD050760Chemicals & Drugs24360.986183Cyclin-Dependent Kinase Inhibitor p27https://rosnerlab.comRosner LabUniversity of ChicagoMarshaRosnerMarsha Rosner41.78927490000000-87.60125000000000257Rosner, MarshaProfessortrue1ProfessorProfessorAuthorship 5821410.3647820.3647821authors10.2510has subject area